Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | XIAP | P98170 | 1/20 | 0.51 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29403049 | 0.94 | SLC7A5 (0.58) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL31070713 | 0.89 | SLC15A1 (0.49) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL13696723 | 0.87 | LTA4H (0.64) | LTA4HLAP3LNPEP | |
| SCHEMBL25982889 | 0.86 | SLC7A5 (0.62) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL121369 | 0.86 | SLC7A5 (0.62) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL16080193 | 0.86 | SLC7A5 (0.62) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL630209 | 0.86 | SLC7A5 (0.62) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL26023571 | 0.86 | SLC7A5 (0.62) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL15295143 | 0.86 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL9831417 | 0.85 | SLC7A5 (0.60) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4577952-A1 | LAYER FREEZING AND DATA SIEVING FOR SPARSE TRAINING | SNAP INC (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4417221-A2 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| EP-4343024-A2 | METAL ION BASED CRYSTAL EQUIVALENT BACK (..) CUBES.A NOVEL SUCH AS A BSP. MN4O6LA BIONIC CATALYTIC PHOTOCELL HAVING PROCESS INDICATION FOR WATER SPLITTING IN HYDROGEN AND HYDROGEN | Geier, Stefan A. (DE) | 2024-03-27 | — | — | EP | disclosed |
| EP-4087543-B1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | TYNDALL FORMULATION SERVICES LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2024044004-A1 | LAYER FREEZING AND DATA SIEVING FOR SPARSE TRAINING | SNAP INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11891482-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2024-02-06 | — | — | US | disclosed |
| EP-4087543-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC (US) | 2022-11-16 | — | — | EP | disclosed |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | Tyndall Formulation Services, LLC | 2022-08-11 | — | — | US | disclosed |
| US-11286344-B2 | Polymer excipients for drug delivery applications | Tyndall Formulation Services, LLC (US) | 2022-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286344-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885ALPI 1545/4885PKM 272/4885 |
| US-20220251296-A1 | POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS | CLTB, ACTB, TNNC1 | SLC7A5 20/4885ALPI 1545/4885PKM 272/4885 |
| US-11891482-B2 | Polymer excipients for drug delivery applications | CLTB, ACTB, TNNC1 | SLC7A5 20/4885ALPI 1545/4885PKM 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.